Buscar
Mostrando ítems 81-87 de 87
Response to: Prognostic factors in hospitalized HIV-positive patients with COVID-19: correspondence
(Support UsContactAdmin QJM: An International Journal of Medicine, 2023)
[Abstract not available]
The opioid epidemic during the COVID-19 pandemic: Impact on HIV and HCV control
(NLM (Medline), 2021)
The opioid epidemic is a tragedy in the United States. In the 12-month period that ended in April 2021, more than 100,000 US citizens died of drug overdose, up almost 30% from the 78,000 deaths in the prior year.
Another patient has cured HIV infection
(NLM (Medline), 2021)
Up to date, a sterilizing cure of HIV-1 infection has been reported in only two persons living with HIV-1 who underwent allogeneic hematopoietic stem cell transplantations from donors who were homozygous for the CCR5 Δ32 ...
Determinants of poor clinical outcome in patients with influenza pneumonia: A systematic review and meta-analysis
(International Journal of Infectious Diseases, 2023)
Background: The clinical burden of influenza is increasing worldwide. Aging, immunosuppression, and underlying respiratory illness are determinants of poor clinical outcomes, including greater mortality. Bacterial infections ...
Providing Spiritual Care to In-Hospital Patients During COVID-19: A Preliminary European Fact-Finding Study
(Journal of Religion & Health, 2022)
Historically, there has be a close relationship between the nursing services and spiritual care provision to patients, arising due to the evolvement of many hospitals and nursing programmes from faith-based institutions ...
Testing a vaccine candidate against Hepatitis C virus designed by combinatorial optimization
(Scientific Reports, 2023)
This paper presents a new procedure for vaccine design against highly variable viruses such as Hepatitis C. The procedure uses an optimization algorithm to design vaccines that maximize the coverage of epitopes across ...
Triple Threat: HDV, HBV, HIV Coinfection
(Clinics in Liver Disease, 2023)
First discovered in the late 1970s, hepatitis delta virus (HDV) has emerged as an important driver of decompensated liver disease and hepatocellular carcinoma (HCC) worldwide. HDV requires hepatitis B virus (HBV) for ...